
Global Rapid Drug Screen Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Rapid Drug Screen market size was valued at US$ 6864 million in 2024 and is forecast to a readjusted size of USD 15150 million by 2031 with a CAGR of 12.1% during review period.
Drug screening is a technique for detecting illegal substances in saliva, sperm, and other biological samples. During this process, potential drugs are identified and engineered to proceed to clinical trials until a candidate product is selected. This includes scanning large chemical collections for a specific biological operation in high-throughput screening assays.
Drug abuse and alcohol consumption are increasing worldwide. Rising prevalence of opioid overdose is expected to drive market growth over the forecast period. For example, opioids include compounds extracted from poppy seeds, as well as synthetic and semi-synthetic compounds with similar properties that can interact with opioid receptors in the brain, according to data released by the World Health Organization in 2021. According to the same source, approximately 275 million people worldwide (5.5% of the global population aged 15-64) have used drugs at least once. Of these, about 62 million people use opioids. Alcohol consumption has also seen a similar rise, with the consequence of rising incidences of impaired driving, rising consumption of illicit drugs and alcohol will further boost the development of drug screening products and services.
This report is a detailed and comprehensive analysis for global Rapid Drug Screen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Rapid Drug Screen market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rapid Drug Screen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rapid Drug Screen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rapid Drug Screen market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rapid Drug Screen
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rapid Drug Screen market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Thermo fisher Scientific Inc, Premier Biotech, Inc., LabCorp, Quest Diagnostics, Drägerwerk AG&Co. KGaA, Siemens Healthineers, Quest Diagnostics Incorporated, Alfa Scientific Designs,Inc, Lifeloc Technologies Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Rapid Drug Screen market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Saliva Detection
Urine Examination
Sperm Test
Market segment by Application
Judicial Office
Hospital
Drug Treatment Center
Other
Major players covered
Abbott
Thermo fisher Scientific Inc
Premier Biotech, Inc.
LabCorp
Quest Diagnostics
Drägerwerk AG&Co. KGaA
Siemens Healthineers
Quest Diagnostics Incorporated
Alfa Scientific Designs,Inc
Lifeloc Technologies Inc
OraSure Technologies,Inc
Omega Laboratories,Inc
Shimadzu Corporation
F. Hoffmann-La Roche Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rapid Drug Screen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rapid Drug Screen, with price, sales quantity, revenue, and global market share of Rapid Drug Screen from 2020 to 2025.
Chapter 3, the Rapid Drug Screen competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rapid Drug Screen breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Rapid Drug Screen market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rapid Drug Screen.
Chapter 14 and 15, to describe Rapid Drug Screen sales channel, distributors, customers, research findings and conclusion.
Drug screening is a technique for detecting illegal substances in saliva, sperm, and other biological samples. During this process, potential drugs are identified and engineered to proceed to clinical trials until a candidate product is selected. This includes scanning large chemical collections for a specific biological operation in high-throughput screening assays.
Drug abuse and alcohol consumption are increasing worldwide. Rising prevalence of opioid overdose is expected to drive market growth over the forecast period. For example, opioids include compounds extracted from poppy seeds, as well as synthetic and semi-synthetic compounds with similar properties that can interact with opioid receptors in the brain, according to data released by the World Health Organization in 2021. According to the same source, approximately 275 million people worldwide (5.5% of the global population aged 15-64) have used drugs at least once. Of these, about 62 million people use opioids. Alcohol consumption has also seen a similar rise, with the consequence of rising incidences of impaired driving, rising consumption of illicit drugs and alcohol will further boost the development of drug screening products and services.
This report is a detailed and comprehensive analysis for global Rapid Drug Screen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Rapid Drug Screen market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rapid Drug Screen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rapid Drug Screen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Rapid Drug Screen market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rapid Drug Screen
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rapid Drug Screen market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Thermo fisher Scientific Inc, Premier Biotech, Inc., LabCorp, Quest Diagnostics, Drägerwerk AG&Co. KGaA, Siemens Healthineers, Quest Diagnostics Incorporated, Alfa Scientific Designs,Inc, Lifeloc Technologies Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Rapid Drug Screen market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Saliva Detection
Urine Examination
Sperm Test
Market segment by Application
Judicial Office
Hospital
Drug Treatment Center
Other
Major players covered
Abbott
Thermo fisher Scientific Inc
Premier Biotech, Inc.
LabCorp
Quest Diagnostics
Drägerwerk AG&Co. KGaA
Siemens Healthineers
Quest Diagnostics Incorporated
Alfa Scientific Designs,Inc
Lifeloc Technologies Inc
OraSure Technologies,Inc
Omega Laboratories,Inc
Shimadzu Corporation
F. Hoffmann-La Roche Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rapid Drug Screen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rapid Drug Screen, with price, sales quantity, revenue, and global market share of Rapid Drug Screen from 2020 to 2025.
Chapter 3, the Rapid Drug Screen competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rapid Drug Screen breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Rapid Drug Screen market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rapid Drug Screen.
Chapter 14 and 15, to describe Rapid Drug Screen sales channel, distributors, customers, research findings and conclusion.
Table of Contents
121 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Rapid Drug Screen by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.